Supreme Court E-Library
Information At Your Fingertips


  View printer friendly version

(NAR) VOL. 11 NOS.1-4 / JANUARY – MARCH 2000

[ BFAD ADMINISTRATIVE ORDER NO. 48-C, S.1999, November 21, 1999 ]

SUBMISSION OF SUGGESTED RETAIL PRICE OF PHARMACEUTICAL PRODUCT AS ADDITIONAL REQUIREMENT FOR PRODUCT REGISTRATION



Republic Act 7581, otherwise known a the “Price Act” states, among other things that, “It is policy of the state to ensure the availability of basic necessities and prime commodities at reasonable prices at all times x x x “.

For the proper implementation of the above policy, with respect to pharmaceutical products, and consistent with the provisions of R.A. 7394 the “Consumer Act” and R.A. 3720 the Foods, Drugs, Devices and Cosmetics Act”, the Bureau of Food and Drugs is hereby ordered to require the submission of a declaration of the “suggested retail price” of pharmaceutical products by the registrant as an additional requirement for product registration, an addendum to Administrative Order 67, s. 1989 “Subject: Requirements for Registration of Pharmaceutical Products”.

For purposes of this Administrative Order, Suggested Retail Price is defined as the proposed amount or cost of a pharmaceutical product per unit item when retailer offers this for sale to the consumer or end-user. Furthermore, unit item refers to per tablet or capsule, per ampoule or vial, or per bottle of a liquid formulation, as purchased in a local drug outlet by the consumer.

This Order shall take effect fifteen (15) days after its publication in a newspaper of general circulation.

Adopted: 21 Nov. 1999

(SGD.) ALBERTO G. ROMUALDEZ, JR. MD.
Secretary of Health

© Supreme Court E-Library 2019
This website was designed and developed, and is maintained, by the E-Library Technical Staff in collaboration with the Management Information Systems Office.